Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CARE
CARE logo

CARE Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Carter Bankshares Inc (CARE) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

No data

No data

Growth

Profitability

Efficiency

Wall Street analysts forecast CARE stock price to fall
1 Analyst Rating
Wall Street analysts forecast CARE stock price to fall
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 26.970
sliders
Low
22
Averages
22
High
22
Current: 26.970
sliders
Low
22
Averages
22
High
22
Freedom Broker
Mikhail Paramonov
Buy
to
Hold
downgrade
$25 -> $27
AI Analysis
2026-05-15
Reason
Freedom Broker
Mikhail Paramonov
Price Target
$25 -> $27
AI Analysis
2026-05-15
downgrade
Buy
to
Hold
Reason
Freedom Broker analyst Mikhail Paramonov downgraded Carter Bankshares to Hold from Buy with a price target of $27, up from $25. The sale of non-performing loans drove a significant increase in EPS and strengthened the balance sheet, the analyst tells investors.
Raymond James
Outperform
maintain
$25 -> $27
2026-04-27
Reason
Raymond James
Price Target
$25 -> $27
2026-04-27
maintain
Outperform
Reason
Raymond James raised the firm's price target on Carter Bankshares to $27 from $25 and keeps an Outperform rating on the shares. Carter Bankshares is positioned to shift to offense following the sale of its Justice nonperforming loans, which removes a longstanding drag on both operations and valuation, the analyst tells investors in a research note. With only a partial Q1 impact reflected, net interest margin and expenses are expected to improve meaningfully in Q2 as liquidity is redeployed into higher-yielding assets, while enhanced strategic flexibility and capital return potential support a more positive valuation outlook, the firm says.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CARE
Unlock Now

People Also Watch